Literature DB >> 11778673

Cholestatic hepatitis caused by acute gold potassium cyanide poisoning.

M L Wu1, W J Tsai, J Ger, J F Deng, S H Tsay, M H Yang.   

Abstract

INTRODUCTION: Poisoning after oral ingestion of gold potassium cyanide is rarely reported. A case of suicidal ingestion of gold potassium cyanide (potassium dicyanoaurate; CAS# 13967-50-5) is described. CASE REPORT: A 27-year-old man attempted suicide by ingesting 5 mL gold potassium cyanide solution. He developed vomiting, hyperamylasemia, and hepatic dysfunction. Cyanide poisoning was not detected but acute gold toxicity was noted. Pathologic findings of the liver showed centrilobular cholestasis with eosinophilic degeneration. The whole blood and serum gold were 4361 and 6011 microg/L, respectively, and the 24-hour urine gold was 429 microg/d in samples obtained on day 4.
CONCLUSION: Gold-induced hepatotoxicity has been seen infrequently in patients receiving gold therapy. Reported agents include sodium aurothiomalate, sodium aurothiopropranol sulfonate, aurothioglucose, aurothiopolypeptide (Auro-detoxin), auric sulfide, and gold thiosulfate, our report adds gold potassium cyanide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11778673     DOI: 10.1081/clt-100108516

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  3 in total

1.  Fatality from potassium gold cyanide poisoning.

Authors:  Elizabeth Harmon; Jacob Lebin; David Murphy; Bjorn Watsjold
Journal:  BMJ Case Rep       Date:  2019-07-26

Review 2.  Removal of Heavy Metals from Wastewaters: A Challenge from Current Treatment Methods to Nanotechnology Applications.

Authors:  Ruxandra Vidu; Ecaterina Matei; Andra Mihaela Predescu; Badriyah Alhalaili; Cristian Pantilimon; Claudia Tarcea; Cristian Predescu
Journal:  Toxics       Date:  2020-11-10

3.  Histological changes in kidney and liver of rats due to gold (III) compound [Au(en)Cl(2)]Cl.

Authors:  Ayesha Ahmed; Dalal M Al Tamimi; Anvarhusein A Isab; Abdulaziz M Mansour Alkhawajah; Mohamed A Shawarby
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.